Dr Joel S Kovarsky, MD | |
1839 Clay Dr, Crozet, VA 22932-2880 | |
(434) 823-5696 | |
Not Available |
Full Name | Dr Joel S Kovarsky |
---|---|
Gender | Male |
Speciality | Internal Medicine - Rheumatology |
Location | 1839 Clay Dr, Crozet, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801800768 | NPI | - | NPPES |
6055893 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 0101053727 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joel S Kovarsky, MD 1839 Clay Dr, Crozet, VA 22932-2880 Ph: (434) 823-5696 | Dr Joel S Kovarsky, MD 1839 Clay Dr, Crozet, VA 22932-2880 Ph: (434) 823-5696 |
News Archive
Workers who lost their job through no fault of their own were twice as likely as continuously employed workers to report over the next 18 months that they developed a new illness, such as high blood pressure, diabetes or heart disease, according to a study released last week, the New York Times reports.
Members of Congress received more than 2500 emails, messages, and stories from lupus advocates across the country during the Lupus Foundation of America's Thirteenth Annual Advocacy Day held February 28-March 1, 2011. More than 200 individuals met in person with their Congressional Representatives and staff on Capitol Hill, and countless others called, wrote letters, or helped spread the word online through Facebook and Twitter, to raise awareness about the need for increased federal funding for lupus research, education, and awareness programs.
The Society of Nuclear Medicine (SNM) and the Society for Pediatric Radiology's Board of Directors recently approved new North American Guidelines for Radiopharmaceutical Doses for Children. These societies have expanded their pediatric radiation protection initiative by standardizing doses (based on body weight) for 11 nuclear medicine procedures commonly performed in children. The Alliance for Radiation Safety in Pediatric Imaging has collaborated in this effort, and will support efforts to promote the new, lower radiopharmaceutical doses.
AlphaRx Inc. has announced that it has completed the lyophilization process for Zysolin(TM), allowing the company to proceed to clinical batch material manufacturing for human trials. This process has been solely developed by AlphaRx's scientists and the resulting formulations have been successfully tested in animal studies conducted by the U.S. Army under a Material Transfer Agreement.
› Verified 8 days ago
Dr. Donald Gray Heppner Jr., M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1041 Half Mile Branch Rd, Crozet, VA 22932 Phone: 703-598-1940 |